taVNS Therapy for Social Anxiety Disorder
Official title: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)for Social Anxiety Disorder: A Randomized Controlled Clinical Trial.
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07772401 · Data updated 2026-11-12
This study tests whether non-invasive taVNS can help reduce social anxiety symptoms in adults with SAD.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Locations | 2 sites (Hangzhou, Zhejiang and 1 other locations) |
| Status | Recruiting |
| Started | September 5, 2025 |
| Main results expected | August 31, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT07772401 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with a DSM-5 diagnosis of Social Anxiety Disorder and LSAS ≥30 and CLASPI >30, who consent to participate.
✕Probably not a fit
Individuals without a reduction in symptoms or with adverse events limiting participation may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, sham-controlled pilot study evaluating transcutaneous auricular vagus nerve stimulation (taVNS) for social anxiety disorder. Participants receive either active taVNS or sham stimulation using identical devices, with stimulation intensity tailored to tolerance (up to 5 mA) or a sham 0.1 mA. The trial aims to assess preliminary efficacy on social anxiety symptoms and to monitor safety and treatment adherence. Outcomes will inform future larger trials in this area.
Why it matters
Potential benefit: If successful, taVNS could offer a non-invasive treatment option to reduce social anxiety symptoms.
How similar studies have gone: Prior small studies suggest potential anxiolytic effects of taVNS, but rigorous evidence in SAD is still emerging.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Fulfillment of the DSM-5 diagnostic criteria for Social Anxiety Disorder (SAD). A Liebowitz Social Anxiety Scale (LSAS) score of ≥30 and a Clinical Global Social Phobia Inventory score greater than 30 Age between 18 and 70 years. Voluntary provision of written informed consent. Exclusion Criteria: A lifetime history of bipolar disorder, schizophrenia, or obsessive-compulsive disorder. Any cognitive impairments that could interfere with the study. Significant suicidal ideation or behavior within the past six months. Patients with rapidly deteriorating conditions. Previous taVNS treatment within the past month. Contraindications to auricular vagus nerve stimulation, such as ear infections, inflammation, skin lesions, or hypersensitivity of the ear. Presence of a pacemaker or other implanted medical devices, or severe neurological, renal, cardiovascular, or hepatic diseases. Concurrent engagement in any form of psychotherapy. History of psychotropic medications or alcohol abuse. Inability to comply with psychological assessments. Incapable of providing informed consent. Pregnant or lactating. Other reasons as deemed unsuitable for inclusion by the research team.
Where it's running
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting -
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Not yet recruiting
Study contacts
- Principal investigator: Han Xu — The Second Affiliated Hospital Zhejiang University of medicine
- Study coordinator: Bin Gao
- Email: zjugaobin@163.com
- Phone: +8618768188021
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Workshops to help undergraduates with social anxiety and public speaking fears
This study is testing different workshop formats to see if they can help college students with social anxiety and fear of public speaking feel more comfortable and confident.
-
Anxiety Skills Study: See if video skill training plus therapy helps people with anxiety
This study tests whether a brief video-based skill training can help people with anxiety as well as four therapy sessions, and how durable the effects are over a year.
-
Metacognitive Therapy vs Cognitive-Behavioral Therapy for Anxiety Disorders
This study asks people with generalized anxiety disorder, social anxiety disorder, or PTSD to share their experiences after trying metacognitive therapy or disorder-specific cognitive-behavioral therapy in a randomized trial.
-
VR exposure therapy versus sertraline for social anxiety in teens
This study will test whether virtual reality exposure therapy or the medication sertraline works better for adolescents aged 12–17 with social anxiety.
-
Mindful Self-Compassion delivered in person versus by video for anxiety and depression
This project will see if an 8-week Mindful Self-Compassion class delivered in person or by video helps people with anxiety or depression have fewer symptoms.
-
Stepped versus stratified care for anxiety in children and adolescents
This project tests whether starting all 8–17-year-olds with anxiety on online CBT and adding in-person CBT only if needed (stepped care) works as well as assigning online or in-person CBT up front based on clinical complexity (stratified care).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.